Tag: phase
Alzheimer’s: a new phase of trials for a treatment will begin
Cuba will begin new clinical trials on a drug developed by a national laboratory to treat Alzheimer’s disease, which is among the leading causes of death on the island, the…
WhatsApp: the modification of sent messages is in the test phase on Android
WhatsApp is testing a feature that will change the content of sent messages. Only subscribers to the Google Play Beta program on Android are currently able to test it. Rumor…
DBV Technologies Provides Update on VITESSE Phase 3 Clinical Study
Montrouge, France, September 21 (11:45 p.m. CEST), 2022 DBV Technologies ftake stock of the study clinical phase 3 SPEED DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market:…
DBV Technologies Provides Update on VITESSE Phase 3 Clinical Study
Montrouge, France, September 21 (11:45 p.m. CEST), 2022 DBV Technologies ftake stock of the study clinical phase 3 SPEED DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market:…
DBV Technologies provides update on VITESSE phase 3 clinical study – 09/21/2022 at 23:45
Montrouge, France, September 21 (11:45 p.m. CEST), 2022 DBV Technologies f take stock of the study clinical phase 3 SPEED DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock…
Nicox: last patient visit for the phase III study – 09/19/2022 at 10:53
(CercleFinance.com) – Nicox announced on Monday that it had completed the last patient visit as part of its phase III clinical study devoted to eye drops NCX 470 in the…
Quantum Genomics: Phase III results expected in November – 09/19/2022 at 12:18
(CercleFinance.com) – Quantum Genomics rose by more than 8% on the Paris Stock Exchange on Monday after announcing its intention to present the results of its phase III study in…
Nicox: Last Patient Visit for Phase III Study
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
QUANTUM GENOMICS: Quantum Genomics announces the presentation of the results of its phase III FRESH study, in difficult to treat/resistant hypertension, on November 4, 2022 at the annual meeting of the American Heart Association (AHA) – 09/19/2022 at 07:30
Quantum Genomics Announces Results Presentation of its phase III FRESH study, in difficult-to-treat/resistant hypertension, November 4, 2022 at the American Heart Association (AHA) Annual Meeting Quantum Genomics (Euronext Growth –…
The Division Heartland: How to register for the test phase?
In May 2021, Ubisoft announced without warning a new The Division game. If the details about it are relatively thin, we still know that we will be dealing with a…
Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022 – 09/12/2022 at 08:00
Additional positive TG6002 Phase I data show that the oncolytic virus is able to reach the tumor, replicate and express its payload in all patients when administered intravenously Strasbourg, France,…
Phase I data of TG6002 presented at ESMO 2022 confirms the potential of Transgene’s Invir.IO™ oncolytic viruses administered intravenously to treat solid tumors – 09/12/2022 at 08:00
The new positive data from the Phase I trial of TG6002 show in all patients that this oncolytic virus, administered intravenously, is capable of reaching the tumor, multiplying there and…